世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Wound Debridement Market - A Global and Regional Analysis: Focus on Product, Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2030


Global Wound Debridement Market Overview The global wound debridement market is projected to experience substantial growth over the forecast period 2023-2030. Moreover, the market value for 2023... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
BIS Research
ビーアイエスリサーチ
2024年4月3日 US$2,499
1-3ユーザライセンス
ライセンス・価格情報
注文方法はこちら
54 英語

 

Summary

Global Wound Debridement Market Overview

The global wound debridement market is projected to experience substantial growth over the forecast period 2023-2030. Moreover, the market value for 2023 was $1,272.0 million, and it is expected to reach $1,898.6 million by 2030, growing at a CAGR of 5.89% during the forecast period. This growth can be attributed to the increasing prevalence of chronic diseases and increasing healthcare expenditure, as well as the rise in surgical procedures. The market includes various types of products, such as ultrasonic debridement, mechanical debridement, enzymatic debridement, and surgical/sharp debridement.

Market Lifecycle Stage

The wound debridement market is currently at a growing stage with a robust growth trajectory, propelled by ongoing innovation within the sector, with companies investing in research and development to introduce more effective, less invasive, and more patient-friendly debridement methods and products. The market has been characterized by a mix of well-established companies and innovative startups, all competing to offer advanced solutions that cater to the evolving demands of research and diagnostics.

Industry Impact

The global wound debridement market has a profound industry impact, driven by the escalating need for efficient wound care management across the healthcare spectrum. The market's growth is closely tied to the rising incidence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, particularly in the aging population and among individuals with diabetes and obesity. The demand for advanced wound debridement technologies and products has been further bolstered by technological advancements, enhancing treatment efficacy and patient comfort. Moreover, the expansion of this market is indicative of a broader shift toward more specialized and effective wound care solutions, reflecting an increasing awareness among healthcare providers and patients alike of the importance of timely and appropriate wound management. This shift not only addresses the immediate needs of wound care but also aligns with broader healthcare goals of reducing hospital stays, preventing complications, and improving overall patient outcomes.

The global wound debridement market continues to drive transformative advancements across industries, with far-reaching implications for human health and environmental sustainability.

Market Segmentation:

Segmentation 1: by Product
• Ultrasonic Debridement
• Enzymatic Debridement
• Mechanical Debridement
• Surgical/Sharp Debridement

Enzymatic Debridement to Dominate the Global Wound Debridement Market (by Product)

Based on product, the enzymatic debridement segment dominated the global wound debridement market in FY2022. The major players that offer enzymatic debridement include Smith & Nephew, MediWound Ltd., SynerHeal Pharmaceuticals, and Virchow.

Segmentation 2: by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World

The global wound debridement market (by region) has been dominated by North America, which held a 43.34% share in 2022. This significant market presence can be attributed to several factors, including the region's advanced healthcare infrastructure, heightened awareness regarding wound care and management, and the increasing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers among its aging population.

Recent Developments in the Global Advanced Wound Debridement Market

• In November 2023, RLS Global and Convatec jointly decided to end their partnership regarding ChloraSolv for the European markets. The commercial rights for ChloraSolv would now revert to RLS Global.
• In September 2023, due to Brexit, medical devices entering the market in Great Britain needed to obtain a so-called UK CA certification. A positive recommendation for the UK CA certification was provided for RLS Global’s wound debridement product, ChloraSolv.
• In July 2022, ChloraSolv was made available in the U.K. to the National Health Service (NHS) entities through the NHS supply chain or directly from ConvaTec. Any NHS facility with an NHS supply chain account had access to ChloraSolv.
• In June 2021, Bioventus and Misonix entered into a final agreement for Bioventus to purchase Misonix.
• In May 2020, Sanara MedTech Inc. announced the execution of a new license agreement with Rochal Industries, LLC, for an autolytic debrider wound dressing currently under development. This agreement strengthened the existing relationship with Rochal Industries and would reflect the dedication to introducing novel and innovative products to the market, particularly in the six focus areas of wound and skin care.

How can this report add value to an organization?

Workflow/Innovation Strategy: The global wound debridement market (by product) has been segmented into detailed segments, including different type of wound debridement products, such as ultrasonic debridement, mechanical debridement, enzymatic debridement, and surgical/sharp debridement.

Growth/Marketing Strategy: A strategic growth and marketing approach for the wound debridement market would involve positioning the company as a leader in innovative solutions that address the evolving needs of hospitals, clinicians, laboratories, and pharmaceutical partners. This would entail leveraging technological advancements to develop products with enhanced sensitivity and specificity while also investing in comprehensive, collaborative partnerships to foster customer loyalty and drive market penetration.

Competitive Strategy: Key players in the global wound debridement market have been focusing on innovation, differentiation, and strategic collaborations to gain a competitive edge. By investing in research and development, companies can develop novel wound debridement products.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• The base year considered for the calculation of the market size is 2022. The historical year analysis has been done from FY2020 to FY2021, and the market size has been calculated for FY2022 and projected for the period 2023-2030.
• The geographical distribution of the market revenue has been estimated to be the same as the company’s net revenue distribution. All the numbers have been adjusted to two digits after decimals for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR has been calculated from 2023 to 2030.
• The market has been mapped based on different types of products available in the market and several indications. All the key manufacturing companies that have a significant number of products for the global wound debridement market have been considered and profiled in the report.
• In the study, the primary respondents' verification was considered to finalize the estimated market for advanced wound debridement.
• The latest annual reports of each market player have been taken into consideration for market revenue calculation.
• Market strategies and developments of key players have been considered for the calculation of sub-segment split.
• The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website or from the annual reports of the respective company, if stated.

Primary Research

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report’s segmentation and key qualitative findings
• Understanding of the numbers of the various markets for market type
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• National Center for Biotechnology Information (NCBI), PubMed, Science Direct, World Bank Group, and World Health Organization (WHO)
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their portfolio
• Gold standard magazines, journals, whitepapers, press releases, and news articles
• Databases

The key data points taken from the secondary sources include:

• Segmentations, split-ups, and percentage shares
• Data for market value
• Key industry trends of the top players in the market
• Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

Several key players dominate the wound debridement market landscape with their diverse range of products and solutions. ConvaTec, Inc., B. Braun SE, DeRoyal Industries, Inc., LifeNet Health, Bioventus Inc., Sanara MedTech Inc., and Smith & Nephew are among the prominent market players offering advanced wound debridement for wound debridement market.

The competition in the wound debridement market has been characterized by a dynamic and intensely competitive landscape with a variety of market players. This competition has been further fuelled by factors such as the increasing prevalence of chronic wounds and the presence of numerous companies offering innovative solutions and services in this field.

ページTOPに戻る


Table of Contents

Executive Summary
1 Markets
1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
1.2.1 Inclusion
1.2.2 Exclusion Criteria
1.3 Key Findings
2 Products
2.1 Product Segmentation
2.2 Product Summary
2.3 Global Wound Debridement Market (by Product Type)
2.3.1 Ultrasonic Debridement
2.3.2 Enzymatic Debridement
2.3.3 Mechanical Debridement
2.3.4 Surgical/Sharp Debridement
3 Regions
3.1 Regional Summary
3.2 North America
3.2.1 U.S.
3.2.2 Canada
3.3 Latin America
3.3.1 Argentina
3.3.2 Brazil
3.3.3 Chile
3.3.4 Colombia
3.3.5 Mexico
3.4 Europe
3.4.1 France
3.4.2 U.K.
3.4.3 Spain
3.4.4 Italy
3.4.5 Portugal
3.4.6 Netherlands
3.4.7 Ireland
3.4.8 Belgium
3.4.9 Switzerland
3.4.10 Norway
3.4.11 Denmark
3.4.12 Sweden
3.4.13 Finland
3.4.14 Germany
3.4.15 Czech Republic
3.4.16 Russia
3.4.17 Poland
3.4.18 Austria
3.4.19 Romania
3.4.20 Slovakia
3.4.21 Greece
3.4.22 Turkey
3.4.23 Ukraine
3.5 Asia-Pacific
3.5.1 Australia
3.5.2 Japan
3.5.3 Malaysia
3.5.4 China
3.5.5 India
3.5.6 Thailand
3.5.7 South Korea
3.6 Rest-of-the-World
4 Markets - Competitive Benchmarking & Company Profiles
4.1 Key Strategies and Developments
5 Research Methodology
5.1 Data Sources
5.1.1 Primary Data Sources
5.1.2 Secondary Data Sources
5.1.3 Data Triangulation
5.2 Market Estimation and Forecast
List of Figures
Figure 1: Global Wound Debridement Market, $Million, 2023, 2026, and 2030
Figure 2: Global Wound Debridement Market (by Region), $Million, 2022, 2026, and 2033
Figure 3: Global Wound Debridement Market (by Product), $Million, 2022, 2026, and 2033
Figure 4: Key Strategies Adopted by Market Players, 2021-2024
Figure 5: Key Industrial Developments in Global Wound Debridement Market, 2023
Figure 6: Strategic Initiatives, 2021-2024
Figure 7: Share of Strategic Initiatives, 2021-2024
Figure 8: Data Triangulation
Figure 9: Top-Down and Bottom-Up Approach
Figure 10: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Global Wound Debridement Market, Opportunities
Table 3: Global Wound Debridement Market (by Product), $Million, 2021-2030
Table 4: Global Wound Debridement Market (by Region), $Million, 2021-2030
Table 5: North America Wound Debridement Market (by Product), $Million, 2021-2030
Table 6: U.S. Wound Debridement Market (by Product), $Million, 2021-2030
Table 7: Canada Wound Debridement Market (by Product), $Million, 2021-2030
Table 8: Latin America Wound Debridement Market (by Product), $Million, 2021-2030
Table 9: Argentina Wound Debridement Market (by Product), $Million, 2021-2030
Table 10: Brazil Wound Debridement Market (by Product), $Million, 2021-2030
Table 11: Chile Wound Debridement Market (by Product), $Million, 2021-2030
Table 12: Colombia Wound Debridement Market (by Product), $Million, 2021-2030
Table 13: Mexico Wound Debridement Market (by Product), $Million, 2021-2030
Table 14: Europe Wound Debridement Market (by Product), $Million, 2021-2030
Table 15: France Wound Debridement Market (by Product), $Million, 2021-2030
Table 16: U.K. Wound Debridement Market (by Product), $Million, 2021-2030
Table 17: Spain Wound Debridement Market (by Product), $Million, 2021-2030
Table 18: Italy Wound Debridement Market (by Product), $Million, 2021-2030
Table 19: Portugal Wound Debridement Market (by Product), $Million, 2021-2030
Table 20: Netherlands Wound Debridement Market (by Product), $Million, 2021-2030
Table 21: Ireland Wound Debridement Market (by Product), $Million, 2021-2030
Table 22: Belgium Wound Debridement Market (by Product), $Million, 2021-2030
Table 23: Switzerland Wound Debridement Market (by Product), $Million, 2021-2030
Table 24: Norway Wound Debridement Market (by Product), $Million, 2021-2030
Table 25: Denmark Wound Debridement Market (by Product), $Million, 2021-2030
Table 26: Sweden Wound Debridement Market (by Product), $Million, 2021-2030
Table 27: Finland Wound Debridement Market (by Product), $Million, 2021-2030
Table 28: Germany Wound Debridement Market (by Product), $Million, 2021-2030
Table 29: Czech Republic Wound Debridement Market (by Product), $Million, 2021-2030
Table 30: Russia Wound Debridement Market (by Product), $Million, 2021-2030
Table 31: Poland Wound Debridement Market (by Product), $Million, 2021-2030
Table 32: Austria Wound Debridement Market (by Product), $Million, 2021-2030
Table 33: Romania Wound Debridement Market (by Product), $Million, 2021-2030
Table 34: Slovakia Wound Debridement Market (by Product), $Million, 2021-2030
Table 35: Greece Wound Debridement Market (by Product), $Million, 2021-2030
Table 36: Turkey Wound Debridement Market (by Product), $Million, 2021-2030
Table 37: Ukraine Wound Debridement Market (by Product), $Million, 2021-2030
Table 38: Asia-Pacific Wound Debridement Market (by Product), $Million, 2021-2030
Table 39: Australia Wound Debridement Market (by Product), $Million, 2021-2030
Table 40: Japan Wound Debridement Market (by Product), $Million, 2021-2030
Table 41: Malaysia Wound Debridement Market (by Product), $Million, 2021-2030
Table 42: China Wound Debridement Market (by Product), $Million, 2021-2030
Table 43: India Wound Debridement Market (by Product), $Million, 2021-2030
Table 44: Thailand Wound Debridement Market (by Product), $Million, 2021-2030
Table 45: South Korea Wound Debridement Market (by Product), $Million, 2021-2030
Table 46: Rest-of-the-World Wound Debridement Market (by Product), $Million, 2021-2030

ページTOPに戻る


Press Release

The global wound debridement market is estimated to reach $1,898.6 million by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 5.89% during the forecast period 2023-2030.

The growth of the wound debridement industry is primarily fuelled by the rising global incidence of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, especially within the aging population. This increase in wound prevalence is coupled with a heightened awareness among healthcare providers and patients about the critical role of effective wound management in promoting faster healing and preventing complications. Technological advancements in debridement methods, including more efficient and less invasive techniques, have significantly contributed to the industry's expansion by offering improved patient outcomes and comfort.

USPs of this report

• Extensive product benchmarking of the top players to offer a holistic view of the market product landscape
• Market size and forecast by detailed segmentation, including product and region
• Region-level analysis, including market size and forecast
• Country-level analysis, including market size and forecast

Analyst Perspective

According to Swati Sood, Principal Analyst, BIS Research, “The market is expected to witness significant growth driven by substantial growth and innovation in the coming years. The convergence of demographic shifts, particularly the aging population and the rising prevalence of diabetes and obesity, underpins a growing demand for effective wound care solutions. The enzymatic debridement segment, with its less invasive nature and high specificity, stands out for its significant contributions to market growth, reflecting a broader industry trend toward developing patient-friendly and cost-effective treatments. Technological advancements are driving the evolution of wound debridement, with a notable shift toward products that enhance healing, reduce infection risks, and improve the quality of life for patients. The market's growth stage in its lifecycle suggests not only a period of robust expansion but also opportunities for new entrants and innovation in product development and delivery models.

The increasing focus on healthcare efficiency and outcomes, combined with favorable reimbursement policies in many countries, is expected to further incentivize the adoption of advanced wound debridement methods. However, this market also faces challenges, including the need for extensive training for healthcare providers and ensuring access across all care settings.”

Key Questions Answered in the Report

• What is the estimated global market size for the wound debridement market?
• What are the key findings in the wound debridement market?
• How is each application segment of the wound debridement market expected to grow during the forecast period, and what is the anticipated revenue generated by each of the segments by the end of 2030?
• How is each product segment of the wound debridement market expected to grow during the forecast period, and what is the anticipated revenue generated by each of the segments by the end of 2030?
• What is the growth potential of the global wound debridement market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World?
• Who are the leading players with significant offerings in the wound debridement market?
• What strategies have been adopted by the key players in the wound debridement market?
• How is each country of the wound debridement market expected to grow during the forecast period, and what is the anticipated revenue generated by product segments by the end of 2030?

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

BIS Research社のヘルスケア分野での最新刊レポート


よくあるご質問


BIS Research社はどのような調査会社ですか?


多数のアナリストチームと大規模な業界専門家のネットワークを擁するBISリサーチは、市場に影響を与える革新的な技術に関して、高度なマーケットインテリジェンスを提供しています。特に、新興テクノロジーに関す... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る